Universal Infectious Disease Assay Facilitated by CRISPR Mediated Depletion - Jumpcode Genomics

    Jon Armstrong - Vice President, Research & Development at Jumpcode Genomics

    • Comparative performance of NGS platforms in a novel universal infectious disease assay
    • AVITI™ highly concordant in identifying all COVID samples tested regardless of Ct value
    • AVITI highly concordant in identifying all 49 non-human organisms tested

    Download App Note

    Contact Sales

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.